Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Castration-resistant Prostate Cancer
Related studies linked through entity extraction aliases.
Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
- Status
- COMPLETED
- Phase
- PHASE3